Physician profile
Mark C Bucy
NPI 1639194723
$1,507.42
in general payments reported to CMS, 2019-2025
17 companies · $104 in 2025
The $104 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $179 · 2021: $568 · 2022: $138 · 2023: $76.43 · 2024: $36.30 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $441.62 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $177.54 | 2021-2022 | |
| Cranial Technologies, INC | $141.02 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $116.10 | 2019-2024 | Trintellix |
| Ars Pharmaceuticals Operations, INC. | $103.71 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $88.28 | 2021-2023 | Gardasil 9, M-M-R II, Vaxneuvance |
| Ironshore Pharmaceuticals INC. | $84.14 | 2019-2022 | |
| Sanofi Pasteur INC. | $73.42 | 2019-2023 | |
| Tris Pharma INC | $72.55 | 2019-2021 | |
| Neos Therapeutics, LP | $50.69 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $36.72 | 2019-2020 | |
| Adlon Therapeutics L.P. | $36.29 | 2019-2021 | |
| Alk-Abello, INC | $20.00 | 2024 | Odactra, Ragwitek, Grastek |
| Corium, LLC | $18.48 | 2021 | |
| Quidel Corporation | $15.84 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $15.54 | 2019 | |
| Aytu Biopharma, INC. | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bucy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.